Latest news for OncoVista Innovative (OTC:OVIT) Stock

OncoVista Innovative Therapies Inc is a biopharmaceutical company. It is engaged in developing anticancer therapies by utilizing tumor-associated biomarkers.

News

OVIT

OncoVista Divests AdnaGen Subsidiary for up to $65M

ONCOVISTA INNVTVE THERPS by OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies Inc

<p>OncoVista Innovative Therapies, Inc. (OVIT) recently announced that the Company had divested its majority holding of subsidiary AdnaGen AG. </p>
<p>On October 28, 2010, OncoVista Innovative Therapies, Inc. entered into a Stock Purchase Agreement with a buyer whereby the Company sold all of its shares, representing approximately 78% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG. </p>


OncoVista Innovative

OncoVista Innovative Therapies, Inc. (OVIT) recently announced that the Company had divested its majority holding of subsidiary AdnaGen AG. 

On October 28, 2010, OncoVista Innovative Therapies, Inc. entered into a Stock Purchase Agreement with a buyer whereby the Company sold all of its shares, representing approximately 78% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG. 


Comments

OncoVista Innovative

News

Latest news for OncoVista Innovative (OTC:OVIT) Stock

Thursday, November 11, 2010

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga